Oncternal Therapeutics, Inc.
USD0.53
-0.17 (-24.12%)
CEO
James B. Breitmeyer
IPO Date
2004-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.70
Prev. Close
$0.69
Day Low
$0.53
Day High
$0.70
52W Low
$0.53
52W High
$10.61
Market Cap
$0.00B
Volume
0.64M
| -1.2 |
| 31 Dec 2021 | FY | 96.1% | -725.4% | 27.4% | -33.4% | -0.00 | 16.99 | -23.4 |
| 31 Dec 2020 | FY | -255.6% | -509.9% | 20.8% | -14.5% | -0.00 | 20.14 | -141.0 |
| 31 Dec 2019 | FY | -318.9% | -656.2% | -111.2% | -73.2% | 0.01 | 2.83 | -2.6 |
| 31 Dec 2018 | FY | 98.2% | -1523.9% | -147.1% | -122.7% | 1.78 | 5.99 | -9.5 |
| 31 Dec 2017 | FY | 97.2% | -1818.3% | -79.6% | -65.8% | 0.01 | 5.78 | -14.6 |
| 31 Dec 2016 | FY | 200.0% | 705.9% | -89.1% | -72.3% | 0.00 | 5.27 | -8.7 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -1006.1% | -58.4% | 0.00 | 1.06 | -10.5 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -221.0% | -77.8% | 0.00 | 1.53 | -3.0 |
| -0.6 |
| 31 Mar 2024 | Q1 | -964.9% | -1474.2% | -36.6% | -28.8% | 0.01 | 4.66 | -0.8 |
| 31 Dec 2023 | Q4 | -2145.8% | -3085.5% | -30.5% | -25.0% | 0.01 | 6.94 | -0.9 |
| 30 Sept 2023 | Q3 | 58.1% | -5509.5% | 5.2% | -22.8% | -0.00 | 8.25 | -0.4 |
| 30 Jun 2023 | Q2 | 65.1% | -8458.5% | 5.0% | -17.7% | -0.00 | 10.37 | -0.6 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -21.9% | -19.7% | 0.00 | 10.55 | -1.0 |
| 31 Dec 2022 | Q4 | 79.5% | -6365.5% | 6.9% | -15.9% | -0.00 | 8.76 | -1.3 |
| 30 Sept 2022 | Q3 | 90.8% | -2807.6% | -15.6% | -14.1% | 0.00 | 9.81 | -6.7 |
| 30 Jun 2022 | Q2 | 66.0% | -6090.6% | -15.7% | -14.3% | 0.00 | 10.78 | -7.7 |